切换至 "中华医学电子期刊资源库"

中华胸部外科电子杂志 ›› 2015, Vol. 02 ›› Issue (04) : 222 -226. doi: 10.3877/cma.j.issn.2095-8773.2015.04.003

所属专题: 文献

综述

体外肺灌注在肺移植中的研究进展
张航1, 崔键1,()   
  1. 1. 150000 黑龙江省哈尔滨医科大学附属第四医院胸外科
  • 收稿日期:2015-04-15 出版日期:2015-11-28
  • 通信作者: 崔键

Development of ex vivo lung perfusion in lung transplantation

Hang Zhang1, Jian Cui1,()   

  1. 1. Department of Thoracic Surgery, Fourth Affiliated School of Clinical Medicine, Harbin Medical University, Harbin 150000, China
  • Received:2015-04-15 Published:2015-11-28
  • Corresponding author: Jian Cui
  • About author:
    Corresponding author: Cui Jian, Email:
引用本文:

张航, 崔键. 体外肺灌注在肺移植中的研究进展[J/OL]. 中华胸部外科电子杂志, 2015, 02(04): 222-226.

Hang Zhang, Jian Cui. Development of ex vivo lung perfusion in lung transplantation[J/OL]. Chinese Journal of Thoracic Surgery(Electronic Edition), 2015, 02(04): 222-226.

肺移植是治疗晚期肺实质和肺血管疾病的最佳选择,也是延长患者生存期和提高生活质量的重要干预措施。过去的几十年中,在一些欧美国家肺移植研究迅速发展。体外肺灌注(EVLP)作为一种现代的肺移植供肺保护技术,能够评估供肺情况并改善供肺质量,将评估后的高危供肺成功移植,从而也安全地增加了供体数量。该文就EVLP技术在肺移植领域的最新研究应用进展进行综述。

Developed rapidly in some European and American countries over the past decades, lung transplantation has been accepted as the best therapy that improves the survival and quantity of life for selected patients with end-stage lung or pulmonary vascular diseases. Ex vivo lung perfusion(EVLP) has emerged as a modern preservation technique that allows for more accurate lung assessment and also improvement of lung quality. Its application in high risk donor lungs has led to safe and substantial expansion of the donor pool. This paper reviews the growing development of EVLP application in lung transplantation.

表1 三大EVLP系统比较
[1]
Yusen RD, Christie J, Edwards LB, et a1. The Registry of the International Society for Heart and Lung Transplantation: thirtieth adult lung and heart-lung transplant report-2013[J].J Heart Lung Transplant,2013,32(10): 965-978.
[2]
Benden C, Edwards LB, Kucheryavaya AY, et a1. The Registry of the International Society for Heart and Lung Transplantation: sixteenth official pediatric lung and heart-lung transplantation report-2013[J].J Heart Lung Transplant,2013,32 (10): 989-997.
[3]
Trulock EP, Christie JD, Edwards LB, et al. Registry of the International Society for Heart and Lung Transplantation: twenty-fourth official adult lung and heart-lung transplantation report—2007[J].J Heart Lung Transplant,2007,26(8):782-795.
[4]
Gomez-de-Antonio D, Varela A. Non-heart-beating donation in Spain[J].Gen Thorac Cardiovasc Surg,2011,59(1):1-5.
[5]
Steen S, Sjoberg T, Pierre L, et al. Transplantation of lungs from a non-heart-beating donor[J].Lancet,2001,357:825-829.
[6]
Cypel M, Sato M, Yildirim E, et al. Initial experience with lung donation after cardiocirculatory death in Canada[J]. J Heart Lung Transplant,2009,28:753-758.
[7]
Erasmus ME, Verschuuren EA, Nijkamp DM, et al. Lung transplantation from nonheparinized category III non-heart-beating donors. A single-centre report[J]. Transplantation,2010,89:452-457.
[8]
Love RB.Perspectives on lung transplantation and donation-after-determin-ation-of-cardiac-death donors[J].Am J Transplant,2012,12:2271-2272.
[9]
Mason DP, Brown CR, Murthy SC, et al. Growing singlecenter experience with lung transplantation using donation after cardiac death[J].Ann Thorac Surg, 2012,94:406-411;discussion 411-412.
[10]
De Oliveira NC, Osaki S, Maloney JD, et al. Lung transplantation with donation after cardiac death donors: long-term follow-up in a single center[J].J Thorac Cardiovasc Surg,2010,139:1306-1315.
[11]
Levvey BJ, Harkess M, Hopkins P, et al. Excellent clinical outcomes from a national donation-after-determination-of-cardiac-death lung transplant collaborative[J].Am J Transplant,2012,12:2406-2413.
[12]
Puri V, Scavuzzo M, Guthrie T, et al. Lung transplantation and donation after cardiac death: a single center experience[J].Ann Thorac Surg,2009,88:1609-14; discussion 1614-1615.
[13]
Alessandrini F, D’Armini AM, Roberts CS, et al. When does the lung die? II. Ultrastructural evidence of pulmonary viability after "death" [J].J Heart Lung Transplant,1994,13(5):748-757.
[14]
D’Armini AM, Roberts CS, Griffith PK, et al. When does the lung die? I. Histochemical evidence of pulmonary viability after "death" [J].J Heart Lung Transplant,1994,13(5):741-747.
[15]
Egan TM. Non-heart-beating donors in thoracic transplantation[J].J Heart Lung Transplant,2004,23(1):3-10.
[16]
Van Raemdonck DE, Rega FR, Neyrinck AP, et al. Non-heart-beating donors[J].Semin Thorac Cardiovasc Surg,2004,16(4):309-321.
[17]
Egan TM, Lambert CJ Jr, Reddick R, et al. A strategy to increase the donor pool: use of cadaver lungs for transplantation[J].J Ann Thorac Surg,1991,52(5):1113-1120.
[18]
Ulicny KS Jr, Egan TM, Lambert CJ Jr,et al. Cadaver lung donors: effect of preharvest ventilation on graft function [J].J Ann Thorac Surg,1993,55(5):1185-1191.
[19]
Hammainen P. Re: use of extracorporeal membrane oxygenation as a bridge to primary lung transplant: 3 consecutive, successful cases and a review of the literature[J].J Heart Lung Transplant,2008,27:1186.
[20]
Wallinder A, Ricksten SE, Hansson C, et al. Transplantation of initially rejected donor lungs after ex vivo lung perfusion[J].J Thorac Cardiovasc Surg, 2012,144:1222-1228.
[21]
Ware LB, Wang Y, Fang X, et al. Assessment of lungs rejected for transplantation and implication for donor selection[J].Lancet,2002,360(9333):619-620.
[22]
Carrel A, Lindbergh CA.The culture of whole organs[J].Science,1935,81: 621-623.
[23]
Jirsch DW, Fisk RL, Couves CM, et al. Ex vivo evaluation of stored lungs[J].Ann Thorac Surg,1970,10:163-168.
[24]
Machuca TN, Cypel M. Ex vivo lung perfusion[J].J Thorac Dise,2014,6(8):1054-1062.
[25]
Steen S, Sjöberg T, Pierre L, et al. Transplantation of lungs from a non-heart-beating donor[J].Lancet,2001,357:825-829.
[26]
Steen S, Ingemansson R, Eriksson L, et al. First human transplantation of a nonacceptable donor lung after reconditioning ex vivo[J].Ann Thorac Surg, 2007,83:2191-194.
[27]
Cypel M, Yeung JC, Liu M, et al. Normothermic ex vivo lung perfusion in clinical lung transplantation[J].N Engl J Med,2011,364:1431-1440.
[28]
Cypel M, Yeung JC, Machuca T, et al. Experience with the first 50 ex vivo lung perfusions in clinical transplantation[J].J Thorac Cardiovasc Surg, 2012,144:1200-1206.
[29]
Cypel M, Rubacha M, Yeung J, et al. Normothermic ex vivo perfusion prevents lung injury compared to extended cold preservation for transplantation[J].Am J Transplant,2009,9:2262-2269.
[30]
Cypel M, Yeung JC, Hirayama S, et al. Technique for prolonged normothermic ex vivo lung perfusion[J].J Heart Lung Transplant,2008,27:1319-1325.
[31]
Yeung JC, Cypel M, Waddell TK, et al. Update on donor assessment, resuscitation, and acceptance criteria, including novel techniques-non-heart-beating donor lung retrieval and ex vivo donor lung perfusion[J]. Thorac Surg Clin, 2009,19:261-274.
[32]
Medeiros IL, Pêgo-Fernandes PM, Mariani AW, et al. Comparison of lung preservation solutions in human lungs using an ex vivo lung perfusion experimental model[J].Clinics (Sao Paulo), 2012,67: 1101-1106.
[33]
Soares PR, Braga KA, Nepomuceno NA, et al. Comparison between Perfadex and locally manufactured lowpotassium dextran solution for pulmonary preservation in an ex vivo isolated lung perfusion model[J].Transplant Proc,2011,43: 84-88.
[34]
Menezes AQ, Pêgo-Fernandes PM, Cardoso PF, et al. Comparison of celsior and perfadex lung preservation solutions in rat lungs subjected to 6 and 12 hours of ischemia using an ex-vivo lung perfusion system[J].Clinics (Sao Paulo), 2012,67: 1309-1314.
[35]
Steen S, Ingemansson R, Eriksson L, et al. First human transplantation of a nonacceptable donor lung after reconditioning ex vivo[J]. Ann Thorac Surg,2007, 83:2191-2194.
[36]
Erasmus ME, Fernhout MH, Elstrodt JM, et al. Normothermic ex vivo lung perfusion of nonheart-beating donor lungs in pigs: from pretransplant function analysis towards a 6-h machine preservation[J].Transpl Int,2006,19:589-593.
[37]
Cypel M, Yeung JC, Hirayama S, et al. Technique for prolonged normothermic ex vivo lung perfusion[J]. J Heart Lung Transplant,2008,27:1319-1325.
[38]
Steen S, Ingemansson R, Eriksson L, et al. First human transplantation of a nonacceptable donor lung after reconditioning ex vivo[J].Ann Thorac Surg, 2007,83:2191-2194.
[39]
Lindstedt S, Hlebowicz J, Koul B, et al. Comparative outcome of double lung transplantation using conventional donor lungs and non-acceptable donor lungs reconditioned ex vivo[J].Interact Cardiovasc Thorac Surg,2011,12: 162-165.
[40]
Aigner C, Slama A, Hötzenecker K, et al. Clinical ex vivo lung perfusion--pushing the limits[J].Am J Transplant,2012,12: 1839-1847.
[41]
Zych B, Popov AF, Stavri G, et al. Early outcomes of bilateral sequential single lung transplantation after ex-vivo lung evaluation and reconditioning[J].J Heart Lung Transplant,2012,31: 274-281.
[42]
Wallinder A, Ricksten SE, Silverborn M, et al. Early results in transplantation of initially rejected donor lungs after ex vivo lung perfusion: a case-control study[J]. Eur J Cardiothorac Surg, 2014,45: 40-44; discussion 44-45.
[43]
Warnecke G, Moradiellos J, Tudorache I, et al. Normothermic perfusion of donor lungs for preservation and assessment with the organ care system lung before bilateral transplant: a pilot study of 12 patients[J].Lancet,2012,380: 1851-1858.
[44]
Gomez-de-Antonio D, Campo-Canareral JL, Crowley S, et al. Clinial lung transplantion from uncontraled non-heart-beating donors revisited[J].J Heart Lung Transplant,2012,31(4):349-353.
[45]
de Antonio DG, Marcos R, Laporta R, et al. Results of clinical lung transplant from uncontrolled non-heart beating donors[J].J Heart Lung Transplant, 2007,26:529-534.
[46]
Moradiellos FJ, Naranjo JM, Córdoba M, et al. Clinical lung transplantation after ex vivo evaluation of uncontrolled non heart-beating donors lungs: initial experience[J].J Heart Lung Transplant,2011,30:S38.
[47]
Egan T, Blackwell J, Forrest L, et al. Evaluation of human lungs from category 1 non-heart-beating donors (NHBDs) with ex-vivo lung perfusion (EVLP) in the U.S.[J]. Chest,2014,145:635A.
[48]
Ware LB, Fang X, Wang Y, et al. Selected contribution: mechanisms that may stimulate the resolution of alveolar edema in the transplanted human lung[J].J Appl Physiol,2002,93(5):1869-1874.
[49]
Cypel M, Yeung J, Hirayama S, et al. Technique for prolonged normothermic ex vivo lung perfusion[J]. J Heart Lung Transplant,2008,27(12): 1319-25.
[50]
Yeung JC, Wagnetz D, Cypel M, et al. Ex vivo adenoviral vector gene delivery results in decreased vector-associated inflammation pre- and post-lung transplantation in the pig[J].Mol Ther, 2012,20: 1204-1211.
[51]
Emaminia A, Lapar DJ, Zhao Y, et al. Adenosine A2A agonist improves lung function during ex vivo lung perfusion[J].Ann Thorac Surg,2011,92(5): 1840-1846.
[1] 赵淑樱, 张聃. 腹腔镜胃癌外科治疗进展与发展趋势[J/OL]. 中华普外科手术学杂志(电子版), 2024, 18(04): 459-462.
[2] 何羽. 腔镜微创手术治疗分化型甲状腺癌的研究进展[J/OL]. 中华普外科手术学杂志(电子版), 2024, 18(04): 456-458.
[3] 中华医学会器官移植学分会. 中国肺移植气道并发症临床诊疗指南(2024版)[J/OL]. 中华移植杂志(电子版), 2024, 18(05): 266-274.
[4] 黄莹, 李璇, 刘梦杨, 彭桂林, 徐鑫, 韦兵, 杨超. 靶向联合治疗双肺移植术后KRAS和BRAF基因双突变晚期肺腺癌一例[J/OL]. 中华移植杂志(电子版), 2024, 18(05): 298-301.
[5] 寇宛婷, 蔡英华, 周海琴, 吴琼. 肺移植术后谵妄影响因素的范围综述[J/OL]. 中华移植杂志(电子版), 2024, 18(04): 251-256.
[6] 汪子涵, 张瑾, 肖飞, 梁朝阳. 常温体外肺灌注技术治疗肺缺血再灌注损伤的研究进展[J/OL]. 中华移植杂志(电子版), 2024, 18(01): 48-54.
[7] 赵家劲, 谢肖俊. 复发性腹壁切口疝的研究进展[J/OL]. 中华疝和腹壁外科杂志(电子版), 2024, 18(01): 21-24.
[8] 刘璐璐, 何羽. 慢性阻塞性肺病患者睡眠障碍的研究进展[J/OL]. 中华肺部疾病杂志(电子版), 2024, 17(05): 836-839.
[9] 刘凌卉, 程铃, 张小雪, 肖敏. 环状RNA与肺部感染的研究进展[J/OL]. 中华肺部疾病杂志(电子版), 2024, 17(01): 140-143.
[10] 白正林, 高明, 孟增东. 肩关节置换术后假体周围感染的研究进展[J/OL]. 中华肩肘外科电子杂志, 2024, 12(03): 271-276.
[11] 苗楠, 宗子钰. 脑出血后继发性脑损伤与线粒体相关机制的研究进展[J/OL]. 中华神经创伤外科电子杂志, 2024, 10(02): 107-111.
[12] 武继敏, 袁春雨, 王鲁佳, 陈伟霞, 李晓东, 马丽虹. 重复经颅磁刺激治疗脑卒中后中枢性疼痛的研究进展[J/OL]. 中华脑科疾病与康复杂志(电子版), 2024, 14(03): 182-186.
[13] 刘琦, 王守凯, 王帅, 苏雨晴, 马壮, 陈海军, 司丕蕾. 乳腺癌肿瘤内微生物组的研究进展[J/OL]. 中华临床医师杂志(电子版), 2024, 18(09): 841-845.
[14] 陈娟, 邓静敏. 胸部子宫内膜异位综合征的研究进展[J/OL]. 中华临床医师杂志(电子版), 2024, 18(01): 96-100.
[15] 李子健, 王锐, 钟云鹏, 张迪轩, 梁韵娟, 杨超, 何建行, 李树本. 自体肺移植术在胸部恶性肿瘤中的临床应用[J/OL]. 中华胸部外科电子杂志, 2024, 11(03): 193-200.
阅读次数
全文


摘要


AI


AI小编
你好!我是《中华医学电子期刊资源库》AI小编,有什么可以帮您的吗?